Non-Abstinence Outcomes in Methamphetamine Use Disorder (NCT07226596)
Advancing Non-Abstinence Outcomes in the Treatment of Methamphetamine Use Disorder
🩺 Plain-English Summary (8th-Grade Level)
Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge gap by demonstrating the biopsychosocial benefits of reduced methamphetamine use. These data will be used to change current accepted methamphetamine treatment endpoints and accelerate identification of therapies for methamphetamine use disorder.
Who can join: Review the eligibility criteria below.
Location: Psychopharmacology of Addiction Laboratory — Lexington, Kentucky
Age range: 18 Years
🧪 Interventions in This Study
- Contingency Management (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Psychopharmacology of Addiction Laboratory — Lexington, Kentucky
📞 Contact the Study Coordinator
Phone: (859) 257-5388
Email: william.stoops@uky.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Methamphetamine Use Disorder
- Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder — Aurora, Colorado
- Psilocybin Therapy for Methamphetamine Use Disorder and HIV — San Francisco, California
- Psilocybin for Methamphetamine Use Disorder — Birmingham, Alabama
- Methamphetamine and Troriluzole — Lexington, Kentucky
- Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder — Aurora, Colorado
- Deep TMS of Neural Circuits Associated With Stimulant Use Disorder — Palo Alto, California
Explore by condition: All Methamphetamine Use Disorder clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.